Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Toxic Lipid Secretion: The ISR pathway in microgli

Message Board Public Reply | Private Reply | Keep | Replies (2)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 153814
(Total Views: 615)
Posted On: 01/08/2025 5:00:22 PM
Posted By: ohm20
Re: Buddyboy20 #148866
Quote:
Toxic Lipid Secretion: The ISR pathway in microglia was shown to drive the synthesis and release of harmful lipids that contribute to synapse loss, a hallmark of Alzheimer’s disease.
Therapeutic Potential: In mouse models, inhibiting ISR activation or lipid synthesis prevented synapse loss and accumulation of neurodegenerative tau proteins, offering a promising pathway for therapeutic intervention.

It looks like the ISR pathway would either be interrupted or regulated by Leronlimab's down regulation of elF2a, and PKR -
Buddyboy20
https://investorshangout.com/post/view?id=6737021



Quote:
elF2a and PKR would be more inline for viral challenges.

Unfortunately sci-hub does not have that full science paper yet. From the synopsis (https://www.cell.com/neuron/abstract/S0896-6273(24)00875-4 ) the cellular stress is most likely driven by inflammatory assaults accompanied by mitochondrial dysfunction. Leronlimab can help in both cases. In the case of lipids leronlimab would reduce both triglycerides and LDL cholesterol. Lipids go toxic when there is an overabundance of them. APOE4 which is implicated in Alzheimer's is integral in lipid movement and activity. CCR5 blockade has been shown to restrain APOE4s effects. - ohm20
https://investorshangout.com/post/view?id=6738054



It looks like targeting the much narrower ISR pathway is not enough. Calico's targeting of elF2b as an agonist failed in ALS. Leronlimab has much broader reach.

Quote:
Google’s anti-aging company Calico released disappointing trial results of its first ever drug.

Calico’s fosigotifator was tested for amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disease that affects nerve cells in the brain and spinal cord and leads to paralysis. It was part of the HEALEY ALS Platform Trial, which is testing a series of drugs against the condition.

Calico said on Monday that fosigotifator did not meet its primary or secondary goals after a 24-week trial. The treatment failed to slow disease progression or improve respiratory function and quality of life better than the placebo group. However, an “exploratory” high dose of the drug appeared to preserve muscle strength and respiratory function longer than the placebo.

Fosigotifator targets the integrated stress response (ISR), a cellular mechanism that reduces activity in cells in response to internal or environmental stress.

Calico was founded in 2013 by Google to help understand and “tackle” aging. It is now a subsidiary of Alphabet and has absorbed at least as $3.5 billion in funding, STAT news reports .
https://qz.com/google-calico-als-drug-trial-1851734070?



Maybe Calico should input "leronlimab" and "aging" or "leronlimab and "ALS" into Google AI since they seem to know nothing about it.


(13)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us